Lifestance Health Group Inc (LFST)vsMerck & Company Inc (MRK)
LFST
Lifestance Health Group Inc
$7.41
-3.01%
HEALTHCARE · Cap: $2.94B
MRK
Merck & Company Inc
$120.79
-1.42%
HEALTHCARE · Cap: $285.64B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 4300% more annual revenue ($65.77B vs $1.49B). MRK leads profitability with a 13.6% profit margin vs 1.6%. MRK trades at a lower P/E of 32.6x. LFST earns a higher WallStSmart Score of 56/100 (C).
LFST
Buy56
out of 100
Grade: C
MRK
Hold50
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+33.6%
Fair Value
$10.44
Current Price
$7.41
$3.03 discount
Margin of Safety
-49.3%
Fair Value
$80.88
Current Price
$120.79
$39.91 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Earnings expanding 1927.0% YoY
Conservative balance sheet, low leverage
Reasonable price relative to book value
Revenue surging 21.2% year-over-year
Mega-cap, among the largest globally
Strong operational efficiency at 38.6%
Generating 2.9B in free cash flow
Areas to Watch
Distress zone — elevated risk
ROE of 1.6% — below average capital efficiency
1.6% margin — thin
Premium valuation, high expectations priced in
Premium valuation, high expectations priced in
4.9% revenue growth
Elevated debt levels
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : LFST
The strongest argument for LFST centers on EPS Growth, Debt/Equity, Price/Book. Revenue growth of 21.2% demonstrates continued momentum.
Bull Case : MRK
The strongest argument for MRK centers on Market Cap, Operating Margin, Free Cash Flow.
Bear Case : LFST
The primary concerns for LFST are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 128.5x leaves little room for execution misses. Thin 1.6% margins leave little buffer for downturns.
Bear Case : MRK
The primary concerns for MRK are P/E Ratio, Revenue Growth, Debt/Equity.
Key Dynamics to Monitor
LFST profiles as a growth stock while MRK is a value play — different risk/reward profiles.
LFST carries more volatility with a beta of 1.20 — expect wider price swings.
LFST is growing revenue faster at 21.2% — sustainability is the question.
MRK generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
LFST scores higher overall (56/100 vs 50/100) and 21.2% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lifestance Health Group Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
LifeStance Health Group, Inc., provides outpatient mental health services to children, adolescents, adults and geriatrics. The company is headquartered in Scottsdale, Arizona.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?